TNF inhibitors within 3 years of diagnosis had no statistically significant negative link with colorectal, lung or prostate cancer survival. Glucocorticoid use lowered survival across all three.

Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 trial data for inebilizumab, an IgG1 monoclonal antibody targeting CD19, in patients ...

From wetting the bed to acne, we have crunched the numbers on the success rate of every single disability claim. It comes ...

Nat Clin Pract Neurol. 2006;2(9):482-493.

Injury or overuse can lead to muscle strain and immediate or delayed pain. In some instances, you may feel symptoms of weakness and discomfort immediately following physical activity, but in cases of ...